nasdaq

Bright Minds Biosciences toPresent at Upcoming Conferences

October 30, 2025 18:30 ET  | Source: Bright Minds Biosciences NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds…

4 weeks ago

CORRECTION Micron Announces Participation in Investor Event

BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, October 30th…

4 weeks ago

Innovation in the Spotlight: Microvast at All-Energy Australia 2025

MELBOURNE, Australia, Oct. 30, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast", the "Company" or "we"), a global leader…

4 weeks ago

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025

October 29, 2025 20:00 ET  | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE, Md. and SUZHOU, China, Oct. 29, 2025 (GLOBE…

4 weeks ago

authID to Report Third Quarter 2025 Financial Results on November 12, 2025

DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity…

4 weeks ago

Armada Acquisition Corp. II Announces Ticker Symbol to Change to XRPN on Oct 30, 2025

New ticker aligns with new $1 billion strategy for XRP exposure on NASDAQ MIAMI, Oct. 29, 2025 /PRNewswire/ -- Armada Acquisition…

4 weeks ago

ibex Bohol Awarded First-Ever TESDA Enterprise-Based Education and Training Accreditation in Region

Milestone accreditation underscores ibex’s role as a leader in community-focused workforce training October 28, 2025 21:00 ET  | Source: Ibex…

4 weeks ago

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or the…

4 weeks ago

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced…

4 weeks ago

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025

Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible…

4 weeks ago